Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis

Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults

(2018) John Eppensteiner et al.   Frontiers in Immunology

Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis

(2017) Monika Merker et al.   JOURNAL OF NEUROIMMUNOLOGY

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

(2017) Leonie Stolz et al.   Journal of Neuroinflammation

Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage

(2017) Mark A. Petersen et al.   NEURON

The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial

(2017) Sofia Straudi et al.   Trials

Prothrombin and factor X are elevated in multiple sclerosis patients

(2016) Kerstin Göbel et al.   ANNALS OF NEUROLOGY

Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study

(2016) N. Martinelli et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities

(2016) A. H. Schmaier   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Histidine-rich glycoprotein binds DNA and RNA and attenuates their capacity to activate the intrinsic coagulation pathway

(2016) Trang T. Vu et al.   THROMBOSIS AND HAEMOSTASIS

Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells

(2016) Kerstin Göbel et al.   Nature Communications

Polyphosphate as modulator of hemostasis, thrombosis, and inflammation

(2015) J. H. Morrissey et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation

(2015) Jae Kyu Ryu et al.   Nature Communications

The Role of Astrocytes in Multiple Sclerosis Progression

(2015) Jorge Correale et al.   Frontiers in Neurology

Factor XII inhibition reduces thrombus formation in a primate thrombosis model

(2014) A. Matafonov et al.   BLOOD

Serum proteomic analysis of a pre-symptomatic multiple sclerosis cohort

(2014) M. T. Wallin et al.   EUROPEAN JOURNAL OF NEUROLOGY

Thrombotic Processes in Multiple Sclerosis as Manifestation of Innate Immune Activation

(2014) Tatiana Koudriavtseva   Frontiers in Neurology

Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer

(2013) R. S. Woodruff et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit

(2013) Yiming Xu et al.   THROMBOSIS AND HAEMOSTASIS

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele

(2013) Oliviero Olivieri et al.   Journal of the American Heart Association

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding

(2011) A. S. Revenko et al.   BLOOD

Coagulation and innate immune responses: can we view them separately?

(2009) M. Delvaeye et al.   BLOOD

Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis

(2009) Evi Stavrou et al.   THROMBOSIS RESEARCH

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets

(2008) May H. Han et al.   NATURE